Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000.
Migliori GB, Centis R, Fattorini L, Besozzi G, Saltini C, Orefici G, Piersimoni C, Gori A, Cassone A; Italian Multicentre Study on Resistance to Antituberculosis drugs (SMIRA) Study Group. Migliori GB, et al. Among authors: saltini c. Eur Respir J. 2003 Jan;21(1):129-34. doi: 10.1183/09031936.03.00047402. Eur Respir J. 2003. PMID: 12570121 Free article.
Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. SMIRA (Italian Multicentre Study on Antituberculosis Drug Resistance) Study Group.
Migliori GB, Ambrosetti M, Fattorini L, Penati V, Vaccarino P, Besozzi G, Ortona L, Saltini C, Orefici G, Moro ML, Lona E, Cassone A. Migliori GB, et al. Among authors: saltini c. Int J Tuberc Lung Dis. 2000 Oct;4(10):940-6. Int J Tuberc Lung Dis. 2000. PMID: 11055761
Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in Italy.
Migliori GB, Fattorini L, Vaccarino P, Besozzi G, Saltini C, Orefici G, Iona E, Matteelli A, Fiorentini F, Codecasa LR, Casali L, Cassone A; SMIRA (Italian Multicentre Study on Resistance to Anti-tuberculosis drugs) Study Group. Migliori GB, et al. Among authors: saltini c. Int J Tuberc Lung Dis. 2002 Jan;6(1):32-8. Int J Tuberc Lung Dis. 2002. PMID: 11931399
Mycobacterium tuberculosis complex drug resistance in Italy.
Migliori GB, Centis R, Fattorini L, Besozzi G, Saltini C, Scarparo C, Cirillo D, Gori A, Cassone A, Piersimoni C. Migliori GB, et al. Among authors: saltini c. Emerg Infect Dis. 2004 Apr;10(4):752-3. doi: 10.3201/eid1004.030667. Emerg Infect Dis. 2004. PMID: 15211998 Free PMC article. No abstract available.
Chemotherapy and diagnosis of tuberculosis.
Saltini C. Saltini C. Respir Med. 2006 Dec;100(12):2085-97. doi: 10.1016/j.rmed.2006.09.015. Respir Med. 2006. PMID: 17113007 Free article. Review.
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens.
Losi M, Knights AJ, Mariani F, Altieri AM, Paone G, Loxton AG, Chegou NN, Kenneth J, Alma MG, Colizzi V, Walzl G, Saltini C, Boyle J, Amicosante M. Losi M, et al. Among authors: saltini c. Eur Respir J. 2016 Feb;47(2):660-4. doi: 10.1183/13993003.01015-2015. Epub 2015 Nov 19. Eur Respir J. 2016. PMID: 26585425 Free article. No abstract available.
136 results